← All trials
NCT04988646
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 21, 2020
- Primary completion
- Apr 20, 2020
- Completion date
- Apr 28, 2020
- First posted
- Aug 3, 2021
- Last posted
- Aug 3, 2021
- Enrollment
- 56
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- PT. Kimia Farma (Persero) TbkLead sponsor
- PT Pharma Metric LabsOverall official - principal investigator
- PT Pharma Metric LabsStudy director
- PT Pharma Metric LabsCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.